Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 603

1.

Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

Landén M, Högberg P, Thase ME.

J Clin Psychiatry. 2005 Jan;66(1):100-6.

PMID:
15669895
2.

Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.

Landén M, Eriksson E, Agren H, Fahlén T.

J Clin Psychopharmacol. 1999 Jun;19(3):268-71.

PMID:
10350034
3.
4.

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ.

J Clin Psychiatry. 2005 Jun;66(6):686-92.

PMID:
15960560
5.

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM.

J Clin Psychiatry. 2000 Apr;61(4):276-81.

PMID:
10830148
6.
7.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
9.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
10.

Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.

Baldwin D, Bridgman K, Buis C.

J Psychopharmacol. 2006 Jan;20(1):91-6. Epub 2005 Oct 4.

PMID:
16204325
11.

A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.

DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E.

J Clin Psychiatry. 2005 Jul;66(7):844-8.

PMID:
16013899
12.
13.

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.

J Clin Psychiatry. 2006 Nov;67(11):1767-75.

PMID:
17196058
14.

Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology.

Dunn JA, Arakawa R, Greist JH, Clayton AH.

J Clin Psychiatry. 2007 Apr;68(4):525-32.

PMID:
17474807
15.

T3 augmentation of SSRI resistant depression.

Abraham G, Milev R, Stuart Lawson J.

J Affect Disord. 2006 Apr;91(2-3):211-5. Epub 2006 Feb 17.

PMID:
16483669
16.

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.

Neuropsychobiology. 2007;56(2-3):73-85. Epub 2007 Nov 23.

PMID:
18037817
17.
18.

[Comparison of two assessment tools of antidepressant side-effects: UKU scale versus spontaneous notification].

Gruwez B, Gury C, Poirier MF, Bouvet O, Gérard A, Bourdel MC, Baylé FJ, Olié JP.

Encephale. 2004 Sep-Oct;30(5):425-32. French.

PMID:
15627047
19.

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC.

J Clin Psychiatry. 2001 Mar;62(3):185-90.

PMID:
11305705
20.

Supplemental Content

Support Center